Abstract |
Screening of the NCI Diversity Set-1 identified PI-083 (NSC-45382) a proteasome inhibitor selective for cancer over normal cells. Focused libraries of novel compounds based on PI-083 chloronaphthoquinone and sulfonamide moieties were synthesized to gain a better understanding of the structure-activity relationship responsible for chymotrypsin-like proteasome inhibitory activity. This led to the demonstration that the chloronaphthoquinone and the sulfonamide moieties are critical for inhibitory activity. The pyridyl group in PI-083 can be replaced with other heterocyclic groups without significant loss of activity. Molecular modeling studies were also performed to explore the detailed interactions of PI-083 and its derivatives with the beta5 and beta6 subunits of the 20S proteasome. The refined model showed an H-bond interaction between the Asp-114 and the sulfonamide moiety of the PI-083 in the beta6 subunit.
|
Authors | Harshani R Lawrence, Aslamuzzaman Kazi, Yunting Luo, Robert Kendig, Yiyu Ge, Sanjula Jain, Kenyon Daniel, Daniel Santiago, Wayne C Guida, Saïd M Sebti |
Journal | Bioorganic & medicinal chemistry
(Bioorg Med Chem)
Vol. 18
Issue 15
Pg. 5576-92
(Aug 01 2010)
ISSN: 1464-3391 [Electronic] England |
PMID | 20621484
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | Copyright (c) 2010 Elsevier Ltd. All rights reserved. |
Chemical References |
- Anthracyclines
- Naphthoquinones
- Protease Inhibitors
- Proteasome Inhibitors
- Protein Subunits
- Sulfonamides
- PI 083
- Proteasome Endopeptidase Complex
|
Topics |
- Anthracyclines
(chemistry)
- Binding Sites
- Computer Simulation
- Hydrogen Bonding
- Naphthoquinones
(chemical synthesis, chemistry, pharmacology)
- Protease Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Proteasome Endopeptidase Complex
(metabolism)
- Proteasome Inhibitors
- Protein Subunits
(antagonists & inhibitors, metabolism)
- Structure-Activity Relationship
- Sulfonamides
(chemistry)
|